NCT02638298 Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds Status COMPLETED Phase NA
NCT02632994 Master Rollover Protocol for Continued Safety Assessment of Study Drug Status AVAILABLE Phase N/A
NCT02632435 Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment. Status COMPLETED Phase NA
NCT02630251 Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors Status TERMINATED Phase PHASE1
NCT02629926 Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors Status UNKNOWN Phase N/A
NCT02623413 Cohort Study of German Hematological / Oncological Wards to Assess the Effect of Contact Precautions on Nosocomial Colonization With Vancomycin Resistant Enterococci Status UNKNOWN Phase N/A
NCT02622412 Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease Status COMPLETED Phase NA
NCT02608307 Medical Treatment Decision Making Using Adaptive Conjoint Analysis Status TERMINATED Phase N/A
NCT02605083 A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02604225 Trial of Methoxyflurane With Periprostatic Local Anaesthesia to Reduce the Discomfort of TRUS B Status COMPLETED Phase PHASE3
NCT02601274 Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor Status TERMINATED Phase PHASE1
NCT02601248 Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor Status COMPLETED Phase PHASE1
NCT02600299 Effectiveness of a Psycho-educational Group (PEG) Intervention on Supportive Care and Survivorship Issues in Early-stage Breast Cancer Survivors Who Have Received Systemic Treatment Status COMPLETED Phase PHASE2